KUMAR RAMDAS: Open Payments
NPI 1780663898 · MAPLEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,895 in 125 payments from 26 companies in 2025. Trend: 2023 $2,287 · 2024 $2,243 · 2025 $2,895
Food & beverage: $2,895
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 7 | $537 |
| AstraZeneca Pharmaceuticals LP | 20 | $338 |
| Lilly USA, LLC | 14 | $269 |
| Sumitomo Pharma America, Inc. | 20 | $218 |
| Medtronic, Inc. | 1 | $165 |
| Merck Sharp & Dohme LLC | 9 | $162 |
| ANI Pharmaceuticals, Inc. | 8 | $139 |
| PFIZER INC. | 7 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| ABIOMED | 1 | $123 |
Products named: REZDIFFRA, BREZTRI, GEMTESA, MOUNJARO, HAWKONE, VERQUVO, PURIFIED CORTROPHIN GEL, VOQUEZNA.
Industry payments across NJ — which companies pay providers there.
